HMGCR and COVID-19: However, there is still a lack of clinical evidence regarding their effects on the COVID-19 infection and further investigation is being conducted13 HMG-CoA reductase inhibitors (or statins) might lower cardiovascular morbidity related to COVID-19 reducing thus the progression of the disease10,14 Furthermore, the use of non-steroidal anti-inflammatory drugs (NSAIDs) seems to be controversial.